NCT04332406 (3DSPECSTAT) is a clinical trial in Patents With Normal VQ/SPECT, sponsored by University Hospital, Brest.

Who is sponsoring NCT04332406?

NCT04332406 is sponsored by University Hospital, Brest.

What condition does NCT04332406 study?

NCT04332406 studies Patents With Normal VQ/SPECT.

Is NCT04332406 still recruiting?

NCT04332406 is currently completed. Last updated 2 April 2020.

Last reviewed 2020-04-02 · How we verify

NCT04332406: 3DSPECSTAT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Normal Ventilatory and Perfusion Pulmonary Function in TEMP

Completed Last updated 2 April 2020

What this trial tests

trial in Patents With Normal VQ/SPECT in 96 participants. Completed in 15 October 2019.

Timeline

13 June 2019

Primary endpoint
15 October 2019

15 October 2019

Quick facts

Lead sponsor	University Hospital, Brest
Status	Completed
Study type	OBSERVATIONAL
Enrollment	96
Start date	13 June 2019
Primary completion	15 October 2019
Estimated completion	15 October 2019
Sites	1 location across France

Conditions studied

Patents With Normal VQ/SPECT — all drugs for Patents With Normal VQ/SPECT →

Sponsor

University Hospital, Brest

Who can join

18 and older, any sex, with Patents With Normal VQ/SPECT. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Ventilation - perfusion SPECT is attractive for lung function assessement. Unfortunately, it is very difficult to delineate normal to abnormal areas because of physiological uptake heterogeneity. In that context, it would be of interest to build statistical maps from registrered normal studies and propose a new methodology for normal SPECT delineation

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Brest trials

Trials by the same sponsor.

NCT07526688 — Aerobic Physical Activity and Orofacial Myofascial Pain · NA · not yet recruiting
NCT07487155 — Unified Junction of Care, Integrated Treatments and Team Coordination for ADHD in Prison Settings With Substance Use Dis · NA · not yet recruiting
NCT07417605 — Diagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Residual Disease and Post-radiatio · not yet recruiting
NCT07302074 — Understanding of Rare Inflammatory Arthritis in Comparison to Classical Inflammatory Arthritis : Tissular Observations a · NA · recruiting
NCT06441773 — Impact of Respiratory Rehabilitation on Quality of Life in Patients With Metastatic Non-small Cell Lung Cancer Treated W · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04332406 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Brest
Last refreshed: 2 April 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04332406.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing